2nd Quarter - Report
VENN STRATEGIES for REGENERON PHARMACEUTICALS, INC.
Firm
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General issues relating to the biopharmaceutical sector, innovation and health care manufacturing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK BAER | — |
| DREW LITTMAN | — |
| LINDSAY PUNZENBERGER | — |
| LAUREN RELIFORD | — |
| STEPHANIE SILVERMAN | — |
| BRADFORD TALLAMY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.